Grauer & Weil (India) Ltd Valuation Shifts to Very Expensive Amid Market Pressure

Valuation Metrics Reflect Elevated Price Levels

The company’s current price-to-earnings (P/E) ratio stands at 20.32, a figure that, while lower than some of its very expensive peers, still signals a premium valuation. The price-to-book value (P/BV) ratio at 3.01 further underscores this elevated pricing, suggesting investors are paying over three times the book value for each share. These multiples have shifted Grauer & Weil’s valuation grade from expensive to very expensive as of the latest assessment on 22 Jul 2026.

Other valuation indicators such as the enterprise value to EBIT (EV/EBIT) at 17.11 and enterprise value to EBITDA (EV/EBITDA) at 14.88 reinforce the narrative of a richly priced stock. The PEG ratio, which adjusts the P/E for earnings growth, is at 3.01, indicating that the stock’s price growth expectations may be outpacing its earnings growth potential.

Comparative Analysis with Industry Peers

When compared to its commodity chemicals peers, Grauer & Weil’s valuation appears more moderate but still elevated. For instance, Navin Fluorine International trades at a P/E of 58.59 and an EV/EBITDA of 36.20, while Himadri Speciality Chemical commands a P/E of 47.39 and EV/EBITDA of 37.59. Acutaas Chemicals and Sumitomo Chemical also exhibit very expensive valuations with P/E ratios above 44 and EV/EBITDA multiples exceeding 35.

In contrast, companies like Atul and Aarti Industries are rated as fairly valued, with P/E ratios of 25.04 and 33.42 respectively, and EV/EBITDA multiples around 15 to 16. This places Grauer & Weil in a middle ground—more expensive than some but less stretched than the highest-valued peers.

Financial Performance and Returns Contextualise Valuation

Grauer & Weil’s return on capital employed (ROCE) is a robust 26.41%, and return on equity (ROE) stands at 15.16%, indicating efficient capital utilisation and reasonable profitability. However, the dividend yield remains modest at 0.70%, which may limit income appeal for yield-focused investors.

Examining stock returns relative to the Sensex reveals a mixed picture. Over the past week and month, Grauer & Weil has underperformed the benchmark, with returns of -2.27% and -13.75% respectively, compared to Sensex gains of 2.17% and 0.86%. Year-to-date, the stock is down 3.49%, though this is better than the Sensex’s -7.97% decline. Longer-term returns are more favourable, with a 5-year gain of 124.58% significantly outpacing the Sensex’s 44.25%, and a remarkable 10-year return of 400.49% versus the benchmark’s 182.99%.

Price Movement and Market Capitalisation

Grauer & Weil’s share price closed at ₹71.82 on 5 Aug 2026, down from the previous close of ₹78.76. The stock’s 52-week high is ₹99.75, while the low is ₹49.70, indicating a wide trading range and recent weakness. The day’s trading saw a high of ₹78.99 and a low of ₹71.17, reflecting volatility amid valuation concerns.

As a small-cap stock, Grauer & Weil’s market capitalisation is modest, which can contribute to higher price swings and sensitivity to market sentiment. The downgrade in the Mojo Grade from Hold to Sell on 22 Jul 2026, accompanied by a Mojo Score of 42.0, signals a cautious stance from analysts, reflecting the deteriorating valuation attractiveness and recent price weakness.

Implications for Investors

The shift from expensive to very expensive valuation grades suggests that Grauer & Weil’s stock price may be under pressure unless supported by strong earnings growth or operational improvements. The elevated P/E and P/BV ratios, combined with a high PEG ratio, imply that the market is pricing in significant growth expectations that may be challenging to meet.

Investors should weigh the company’s solid ROCE and ROE against its modest dividend yield and recent underperformance relative to the Sensex. The stock’s long-term outperformance is encouraging but may not shield it from near-term valuation corrections given the current premium multiples.

Conclusion: Valuation Caution Advisable Amid Price Pressure

Grauer & Weil’s recent downgrade in valuation grading and share price decline highlight the challenges facing investors in this small-cap commodity chemicals stock. While the company demonstrates strong capital efficiency and has delivered impressive long-term returns, its current valuation multiples suggest limited margin for error.

Investors should carefully monitor earnings trends and sector dynamics before committing fresh capital, as the stock’s premium pricing relative to book value and earnings growth expectations may constrain upside potential. The downgrade to a Sell rating by MarketsMOJO reflects these concerns, urging a cautious approach in the near term.

Ultimately, Grauer & Weil remains a stock with a solid operational foundation but one that currently trades at a valuation level demanding strong future performance to justify its price.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →